SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-13-395375
Filing Date
2013-10-09
Accepted
2013-10-09 17:02:59
Documents
2
Group Members
PILLAR INVEST CORPPILLAR PHARMACEUTICALS II, L.P.PILLAR PHARMACEUTICALS III, L.P.PILLAR PHARMACEUTICALS IV, L.P.YOUSSEF EL ZEIN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d610427dsc13da.htm SC 13D/A 204417
2 EX-99.1 d610427dex991.htm EX-99.1 8091
  Complete submission text file 0001193125-13-395375.txt   214392
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Subject) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-50211 | Film No.: 131143803
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PILLAR INVEST OFFSHORE SAL STARCO CENTER BLOC B FL3, OMAR DAOUK ST BEIRUT M8 2020-3313
Business Address C/O PILLAR INVEST OFFSHORE SAL STARCO CENTER BLOC B FL3, OMAR DAOUK ST BEIRUT M8 2020-3313 0119611363362
Pillar Pharmaceuticals I LP (Filed by) CIK: 0001534425 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A